<?xml version="1.0" encoding="UTF-8"?>
<ref id="b3-1031806">
 <label>3.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Adair</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Sevilla</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Heredia</surname>
    <given-names>CD</given-names>
   </name>
   <name>
    <surname>Becker</surname>
    <given-names>PS</given-names>
   </name>
   <name>
    <surname>Kiem</surname>
    <given-names>HP</given-names>
   </name>
   <name>
    <surname>Bueren</surname>
    <given-names>J</given-names>
   </name>
  </person-group>
  <article-title>Lessons learned from two decades of clinical trial experience in gene therapy for Fanconi anemia</article-title>. 
  <source>Curr Gene Ther</source>. 
  <year>2017</year>;
  <volume>16</volume>(
  <issue>5</issue>):
  <fpage>338</fpage>â€“
  <lpage>348</lpage>.
  <pub-id pub-id-type="pmid">28103787</pub-id>
 </mixed-citation>
</ref>
